Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2010
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799774 Quinoline derivatives and their use as 5-HT6 ligands
09/21/2010US7799772 Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents
09/21/2010CA2499429C Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434308C Synthesis of temozolomide and analogs
09/16/2010WO2010105141A2 Azaporphyrins and applications thereof
09/16/2010WO2010104843A2 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors
09/16/2010WO2010103486A1 Pyrazolo[1,5-a]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
09/16/2010WO2010103094A1 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
09/16/2010WO2010102958A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
09/16/2010WO2010102758A2 Halogenalkylmethylenoxy-phenyl-substituted ketoenols
09/16/2010WO2010088368A3 Imidazopyrazines as protein kinase inhibitors
09/16/2010WO2010068520A3 Substituted imidazoheterocycle derivatives
09/16/2010WO2010056320A3 Pi3k/mtor kinase inhibitors
09/16/2010WO2010056038A3 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
09/16/2010WO2010053583A3 Small molecule cd4 mimetics and uses thereof
09/16/2010US20100235950 Pesticidal plant extract containing loline derivatives
09/16/2010US20100234614 Process for pure irbesartan
09/16/2010US20100234597 PROCESS FOR PRODUCING IMIDAZO[1,2-b]PYRIDAZINE COMPOUND
09/16/2010US20100234591 Biaryl heterocyclic compounds and methods of making and using the same
09/16/2010US20100234588 Synthetic method for ceratamine a and b and analogs thereof
09/16/2010US20100234431 Pyrrolidine compounds
09/16/2010US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
09/16/2010US20100234403 Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
09/16/2010US20100234387 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals
09/16/2010US20100234351 Fused nitrogen-comprising heterocyclic compound
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234348 Compositions and methods for potentiating antibiotic activity
09/16/2010US20100233537 Triazine Containing Electrode Materials for Secondary Batteries
09/16/2010US20100233499 Substrate having ir-absorbing dye with branched axial ligands
09/16/2010US20100230670 Device containing compound having indolocarbazole moiety and divalent linkage
09/16/2010CA2755061A1 Pyrimidine derivatives as mtor inhibitors
09/16/2010CA2754847A1 Halogenalkylmethylenoxy-phenyl-substituted ketoenols
09/16/2010CA2754180A1 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors
09/16/2010CA2753135A1 Pyrazolo[1,5-.alpha.]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
09/15/2010EP2228370A1 N-{1-ý3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl¨ethyl}butyramide, the preparation method and use thereof
09/15/2010EP2227473A2 Polymorphs of a c-met/hgfr inhibitor
09/15/2010EP2227472A1 Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
09/15/2010EP2227471A1 Gamma secretase modulators
09/15/2010EP2227467A1 Isoxazolo-pyridine derivatives
09/15/2010EP2094709B1 Thiazole pyrazolopyrimidines as crf1 receptor antagonists
09/15/2010EP2079690B1 3-aza-bicyclo[3.1.0]hexane derivatives
09/15/2010EP2001887B1 Pyrrolo-quinoxalinone derivatives as antibacterials
09/15/2010EP1866314B1 Novel diazabicyclic aryl derivatives and their medical use
09/15/2010EP1578748B1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
09/15/2010CN101835780A Imidazo [1,2-alpha] pyrazine compounds for treatment of viral infections such as hepatitis
09/15/2010CN101835778A Hdac inhibitors
09/15/2010CN101835776A Fused imidazoles for cancer treatment
09/15/2010CN101831486A Application of mycobacterium tuberculosis Rv1354c gene as medicament target
09/15/2010CN101830921A Novel method for activating 7-halogen of fluoroquinoline-3carboxylic acid and application thereof in forming side chain with secondary amine by using condensation
09/15/2010CN101830904A Preparation method of 4-chloropyrrolo[2,3-d]pyrimidine
09/15/2010CN101830903A Aildenafil citrate crystal form O, preparation method and application thereof
09/15/2010CN101367820B Pyrazole-[1,5-a]indole fluoroform sulphonate-4-dimethylamino-benzyl alkene derivant and method of preparing the same
09/15/2010CN101035792B Novel diazabicyclic aryl derivatives and their medical use
09/15/2010CN101006091B Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
09/14/2010US7795447 4-(Acylaminoacetylamino)imidazole derivatives, e.g., methyl 3-(4-{2-[2-(3,5-Difluorophenyl)acetylamino]pentanoylamino}imidazol-1-yl)butyrate; treating neurodegenerative and/or neurological disorders such as Alzheimer's disease and Down's Syndrome
09/14/2010US7795307 acetylcholinesterase inhibitors, comprising prodrugs of an amphetamine and a methamphetamine compounds, used for treating Alzheimer's disease
09/14/2010US7795267 G protein-coupled receptor antagonists such as phenyl tetrahydro-3-oxo-1,1-diphenyl-3H-oxazolo[3,4-a]pyrazine-7(1H)-carboxylate, used for treating cancer, Alzheimer's disease, dementia, eating disorder, hypertension, glandular disorders, diabetes and hyperlipemia
09/14/2010US7795266 Tetrahydroindolone derivatives for treament of neurological conditions
09/14/2010US7795260 ecteinascidin analogues used for the treatment of of leukaemia, lung cancer, colon cancer, kidney cancer, melanoma, prostate cancer, ovarian cancer, breast cancer, pancreatic epitheloid carcinoma, and cervix epitheloid carcinoma; antitumor and anticarcinogenic agents
09/14/2010US7795259 pyrrolo[2,3-b]pyrazine derivatives used as enzyme inhibitors for the treatment of cardiovascular disorders, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, hypertension, allergic diseases, autoimmune diseases, bone disorders, cancer and viral diseases
09/14/2010US7795248 tyrosine kinase inhibitors such as N-[4-(4-amino-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepin-6-yl)phenyl]-N'-phenylurea, used for treating benign or neoplastic proliferative diseases and autoimmune diseases; antitumor agents
09/14/2010US7795247 13-Cyclohexyl-5-(2-pyrrolidin-1-ylethoxy)-6,7-dihydro-5H-indolo[2.1-a][2]benzazepine-10-carboxylic acid, for example; use for the treatment or prevention of infection by hepatitis C virus
09/14/2010US7795245 Heterobicyclic metalloprotease inhibitors
09/14/2010US7795179 Substituted azole compounds and its preparation and use thereof
09/14/2010CA2549431C Optically active quaternary ammonium salt having axial asymmetry and process for producing .alpha.-amino acid and derivative thereof with the same
09/14/2010CA2487211C Pyrazolo(1,5a) pyrimidine compounds as antiviral agents
09/14/2010CA2458744C Anticancer agents and preparation method of the same
09/14/2010CA2434834C 6-substituted pyrido-pyrimidines
09/14/2010CA2409715C .beta.-carboline derivatives useful as inhibitors of phosphodiesterase
09/10/2010WO2010101949A1 8-substituted quinolines and related analogs as sirtuin modulators
09/10/2010WO2010101230A1 Quinoxaline compounds
09/10/2010WO2010101128A1 Amide compound
09/10/2010WO2010100431A1 Pyrrolopyrimidines used as kinase inhibitors
09/10/2010WO2010100144A1 Fused bicyclic compounds as inhibitors for pi3 kinase
09/10/2010WO2010099938A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010WO2010099698A1 Salts of tetrahydroimidazo [1,5-a] pyrazine derivatives, preparation methods and pharmaceutical use thereof
09/10/2010CA2754457A1 Quinoxaline compounds
09/10/2010CA2754330A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010CA2754058A1 8-substituted quinolines and related analogs as sirtuin modulators
09/10/2010CA2753862A1 Tetrahydro-imidazo[1,5-.alpha.]pyrazine derivatives salts, preparation methods and medicinal use thereof
09/10/2010CA2753730A1 Inhibitors of beta-secretase
09/10/2010CA2753236A1 Pyrrolopyrimidines used as kinase inhibitors
09/09/2010US20100228027 Novel compounds of reverse turn mimetics and the use thereof (2)
09/09/2010US20100228022 Reactive Organometallic Dendrimers
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100228008 Dyes linked to target molecules, oligonucleotides or polynucleotides comprising dye molecules, composite dyes and other compositions useful for detecting or quantifying desirable target molecules
09/09/2010US20100227860 Disalt inhibitors of il-12 production
09/09/2010US20100227814 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes
09/09/2010US20100226969 Compounds for inhibiting protein aggregation, and methods for making and using them
09/08/2010EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii
09/08/2010EP2226322A1 Imidazole carbonyl compound
09/08/2010EP2226318A2 Dye-Azide compounds for dual photherapy
09/08/2010EP2225247A1 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
09/08/2010EP2225238A1 Derivatives of 6,7-dihydro-5h-imidazoý1,2- ¨imidazole-3- carboxylic acid amides
09/08/2010EP2225212A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/08/2010EP2224926A1 Prolyl hydroxylase inhibitors
09/08/2010EP2224920A1 Process for making macrocyclic oximyl hepatitis c protease inhibitors
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 573